[1] Marrero JA, Fontana RJ, Su GL, et al. NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States.Hepatology, 2002,36: 1349-1354.
[2] Bugianesi E, Leone N, Vanni E, et al. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.Gastroenterology, 2002, 123: 134-140.
[3] Arun J, Clements RH, Lazenby AJ, et al. The prevalence of nonalcoholic steatohepatitis is greater in morbidly obese men compared to women.Obes Surg, 2006, 16: 1351-1358.
[4] 中华医学会肝病学分会, 中华医学会感染病学分会. 慢性乙型肝炎防治指南(2015年更新版).临床肝胆学杂志,2015, 31: 1941-1960.
[5] Leiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease.Hepatology,2005,41: 1313-1321.
[6] 中华医学会肝病学分会脂肪肝和酒精性肝病学组.中国非酒精性脂肪性肝病诊疗指南.中国医学前沿杂志,2012, 4: 4-10.
[7] 李静波,刘姝,温博,等.FibroTouch与B超、CT对脂肪肝的诊断价值比较.临床肝胆病杂志,2016, 32: 459-462.
[8] 魏晓怡.B超诊断脂肪肝的临床分析.临沂医学专科学校学报,2005, 27: 60-61.
[9] 刘晓琳,范建高.非酒精性脂肪性肝病的研究进展与展望.现代医药卫生,2017, 33: 641-644.
[10] 杨颖,曲涛.甘油三脂、总胆固醇、γ-谷氨酰转肽酶检测对脂肪肝的临床意义.中国继续医学教育, 2016, 8: 30-31.
[11] 李琼,曾丹.脂肪肝与高血压、高血糖、高血脂、超重的相关性.中国老年学杂志,2011, 31: 4530-4532.
[12] 范永丽,高丽华.脂肪肝患者血清血中低密度脂蛋白的临床观察.中国中医药现代远程教育,2009, 7: 52.
[13] 范彦,黄晓东,张恒.B超诊断肝脏脂肪变性与肝活检符合率的研究.中国现代医学杂志,2009, 19: 3136-3138. |
